Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox-Reference-Cited by-同舟云学术

Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox

Published:2017-05-30 Issue:22 Volume:135 Page:2088-2090
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Strauss Martin H.¹,Hall Alistair S.¹

Affiliation:

1. From North York General Hospital, Toronto, Ontario, Canada (M.H.S.); and Leeds MRC Medical Bioinformatics Centre, Leeds, West Yorkshire, United Kingdom (A.S.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.026112

Reference6 articles.

1. Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction

2. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review

3. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials

4. A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure

5. Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Hypertension in the Asia-Pacific Region: A Structured Review;American Journal of Cardiovascular Drugs;2024-02-08

2. In Reply: Real-World Evidence for Causal Inference—Are We Ready?;Mayo Clinic Proceedings;2023-12

3. Real-World Evidence for Causal Inference—Are We Ready?;Mayo Clinic Proceedings;2023-12

4. Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction;PLOS ONE;2023-09-14

5. New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT;Journal of the American Heart Association;2023-09-05